Techno Medica Co., Ltd. (TYO:6678)

Market Cap	13.80B +4.0%
Revenue (ttm)	11.68B +20.9%
Net Income	1.21B +43.2%
EPS	177.42 +45.2%
Shares Out	6.97M
PE Ratio	11.16
Forward PE	n/a
Dividend	68.00 (3.43%)
Ex-Dividend Date	Mar 30, 2026

Volume	20,300
Open	1,975.00
Previous Close	1,975.00
Day's Range	1,972.00 - 1,998.00
52-Week Range	1,850.00 - 2,787.00
Beta	0.26
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 6, 2026

About Techno Medica

Techno Medica Co., Ltd. engages in the research, development, manufacturing, sales, import, and export of analytical instruments for clinical testing and medical devices in Japan, Europe, the United States, Asia, and internationally. The company offers automated tube selecting and labeling systems, RFID process control system, blood and urine collection support, and pre-analytical instruments. It also provides consumables and maintenance services. Techno Medica Co., Ltd. was incorporated in 1987 and is headquartered in Yokohama, Japan.

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1987
• Employees: 239
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 6678

Financial Performance

In fiscal year 2026, Techno Medica's revenue was 11.24 billion, an increase of 13.44% compared to the previous year's 9.91 billion. Earnings were 1.07 billion, an increase of 6.57%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Oct 6, 2026

Data Sources Report a data error